• Angiotensin 1/2 (2-7) Research Workflows

  2026-08-22

  Angiotensin 1/2 (2-7) supports sequence-defined studies of vasoconstriction, aldosterone release, and renin-angiotensin signaling. Its shorter-fragment design also enables focused comparison in spike–receptor binding assays, where peptide length can alter assay behavior.

• Nystatin (Fungicidin): Assay Workflows

  2026-08-22

  Turn Nystatin (Fungicidin) into a reproducible benchmark for Candida susceptibility, adhesion, and biofilm experiments. This workflow-centered guide also explains how the reference study used ergosterol biology to improve polyene assay design and how to troubleshoot solubility, dosing, and model-dependent variability.

• 5-Methyl-CTP for Stable mRNA Workflows

  2026-08-21

  5-Methyl-CTP helps researchers build mRNA synthesis workflows that prioritize transcript persistence and translation while preserving a controlled experimental comparison with conventional CTP. This guide connects nucleotide-level optimization with the plug-and-display bacterial outer membrane vesicle strategy reported for personalized tumor vaccines.

• Z-IETD-FMK at the Apoptosis–Pyroptosis Interface

  2026-08-20

  A translational perspective on how Z-IETD-FMK can be used to interrogate caspase-8-dependent signaling, activated T-cell biology, TRAIL responses, and the emerging chicken GSDME pyroptosis pathway—while preserving the controls needed to distinguish causal pathway effects from general cytotoxicity.

• Sumatriptan Succinate: Research Workflows

  2026-08-20

  Build more informative serotonergic, inflammation, and drug-metabolism assays with Sumatriptan Succinate, a benchmark 5-HT1 receptor agonist. The workflow pairs receptor-focused concentration screening with enzyme-resolved HPLC-MS analysis to distinguish pharmacology from metabolic artifacts.

• S-Adenosylmethionine in Methionine–Autophagy Assays

  2026-08-19

  S-Adenosylmethionine is more than a methyl donor: it is a powerful experimental variable for connecting methionine metabolism, autophagy, and hepatic stellate cell behavior. This article translates recent curcumol findings into practical assay-design decisions using Ademetionine.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-08-19

  This study uses lineage tracing, CITE-seq, and proliferation analysis to show that liver metastasis-associated macrophages are sustained not only by recruited monocytes but also by local macrophage expansion and phenotypically reprogrammed Kupffer cells. The findings identify macrophage-niche vacancy as a driver of Kupffer cell plasticity and support combined strategies that restrict monocyte recruitment while limiting macrophage proliferation.

• HyperFluor 488 in Hyperoxia-Driven ATII Biology

  2026-08-18

  A translational strategy for using HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody to connect DRP1-associated mitochondrial fission, glycolytic reprogramming, and ATII-cell phenotyping in hyperoxia research.

• Alosetron in Intestinal Signaling Research

  2026-08-18

  Alosetron is a selective 5-HT3 receptor antagonist for separating serotonin-dependent gastrointestinal effects from epithelial polarity pathways. This guide translates CDC42–YAP–EGF–mTOR findings into a rigorous experimental strategy for motility, organoid, and visceral pain signaling research.

• Caspase-3 Fluorometric Assay Kit in Apoptosis

  2026-08-17

  Turn DEVD-dependent protease activity into a quantitative fluorescence workflow for comparing treated and control samples. The assay is especially useful for mapping downstream caspase-3 activation after combination treatments such as cisplatin and hyperthermia, while built-in controls and orthogonal readouts help distinguish apoptosis from broader cell-death signaling.

• Luminescent ATP Cell Viability Assay Kit I Workflow

  2026-08-17

  The Luminescent ATP Cell Viability Assay Kit I converts intracellular ATP into a rapid, sensitive luminescent readout for proliferation, cytotoxicity, and metabolic studies. Its streamlined workflow is particularly useful for distinguishing cytostatic responses from overt cell death in models such as p21-peptide-treated glioblastoma cells.

• LY2886721: Practical BACE Inhibitor Workflows

  2026-08-16

  LY2886721 supports controlled BACE1 enzyme inhibition across cellular, functional, and transgenic mouse workflows. Its strongest use-case is not simply maximum amyloid beta reduction, but linking dose-dependent APP processing changes with synaptic-function measurements and translational biomarkers.

• Anisomycin: JNK Signaling as an Assay Perturbation

  2026-08-15

  Anisomycin is a JNK agonist best understood as a mechanistic perturbation tool rather than a generic apoptosis switch. This guide connects JNK pathway activation in apoptosis with new insights into proteolytic control of social-memory maintenance, while defining practical assay boundaries.

• Ruxolitinib in Anaplastic Thyroid Cancer

  2026-08-14

  A 2024 Cell Death and Disease study identifies a mechanistic link between JAK1/2–STAT3 activity, DRP1 transcription, mitochondrial fission, and coordinated apoptosis plus GSDME-mediated pyroptosis in anaplastic thyroid carcinoma. The work positions ruxolitinib as a pharmacological probe for testing mitochondrial-dynamics-dependent cell death in this aggressive cancer, while its clinical relevance remains to be validated.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-08-14

  The reference study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node lipid pathway in which prostaglandin I2 signals through cAMP-PKA to enhance CD86 expression and activation-induced cytidine deaminase in B cells.

8433 records 1/563 page Next 12345 下5页 Last page